Literature DB >> 3747343

Angiotensin II control of the renal microcirculation: effect of blockade by saralasin.

M Steinhausen, H Kücherer, N Parekh, S Weis, D L Wiegman, K R Wilhelm.   

Abstract

The hydronephrotic rat kidney with intact circulation and innervation was split and spread out as a thin sheet in a tissue bath. The microvasculature was observed in vivo via television microscopy. We quantitated the effects of increasing concentrations (10(-9) to 10(-5) M) of saralasin (angiotensin II antagonist) applied locally in the tissue bath on microvascular diameters and on relative glomerular blood flow (measured using fluorescent labeled RBCs). Saralasin produced an increase in preglomerular diameters which was largest (37 +/- 11%) in the interlobular artery (there was no dilation in the afferent arteriole near the glomerulus), an increase in postglomerular diameters which was largest (17 +/- 4%) in the efferent arteriole near the glomerulus, and an increase in blood flow (19 +/- 4%). If these types of findings would hold for the normal kidney, it would suggest a role for angiotensin II in the control of total renal blood flow, in the regional distribution of flow, and in the control of filtration fraction. We also made control micropressure measurements using the servo-nulling approach. Pressures measured were: afferent arteriole, 65 +/- 5 mm Hg; intraglomerulus, 50 +/- 5 mm Hg; and efferent arteriole, 19 +/- 3 mm Hg. These data indicate that there is major vascular resistance near the glomerulus, especially in the efferent arteriole.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3747343     DOI: 10.1038/ki.1986.150

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  4 in total

1.  [Dopaminergic effect of anisodamine on the microcirculation of the hydronephrotic kidney of rats].

Authors:  A P Zou; N Parekh; M Steinhausen
Journal:  J Tongji Med Univ       Date:  1991

Review 2.  [The renin-angiotensin system in diabetic patients].

Authors:  J Mann; E Ritz
Journal:  Klin Wochenschr       Date:  1988-09-15

3.  The angiotensin converting enzyme inhibitor enalapril in acute ischemic renal failure in rats.

Authors:  A M Koelz; S Bertschin; M Hermle; M Mihatsch; F P Brunner; G Thiel
Journal:  Experientia       Date:  1988-02-15

4.  Angiotensin II directly induces muscle protein catabolism through the ubiquitin-proteasome proteolytic pathway and may play a role in cancer cachexia.

Authors:  P M Sanders; S T Russell; M J Tisdale
Journal:  Br J Cancer       Date:  2005-08-22       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.